Search results
ESC Clinical Practice Guidelines aim to present all the relevant evidence on a particular clinical issue in order to help physicians to weigh the benefits and risks of a particular diagnostic or therapeutic procedure. They should be helpful in everyday clinical medical decision-making.
- Cardiomyopathies
This is a new guideline, not an update of existing...
- ESC Guidelines
ESC Guidelines - ESC Clinical Practice Guidelines - European...
- Chronic Coronary Syndromes
Chronic Coronary Syndromes - ESC Clinical Practice...
- Cardio-oncology
This is the first European Society of Cardiology (ESC)...
- Ventricular Arrhythmias and The Prevention of Sudden Cardiac Death
Ventricular Arrhythmias and The Prevention of Sudden Cardiac...
- Guidelines Publication Schedule
Valvular heart disease (Joint Guidelines with EACTS)...
- Cardiac Pacing
Pacing is an important part of electrophysiology and of...
- Heart Failure
The aim of this ESC guideline is to help health...
- Cardiomyopathies
30 sie 2021 · The current guidelines provide recommendations on ASCVD prevention to support shared decision-making by the patient and their healthcare professional based on individual patient characteristics. Special considerations have been given to differences in age, sex and gender, life expectancy, risk factor profiles, ethnic, and geographic differences.
27 sie 2021 · 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC.
All experts involved in the development of these guidelines have submitted declarations of interest. These have been compiled in a report and published in a supplementary document simultaneously to the guidelines. The report is also available on the ESC website www.escardio.org/guidelines
The content of these European Society of Cardiology (ESC) Guidelines has been published for personal and educational use only. No commercial use is authorized. No part of the ESC Guidelines may be translated or reproduced in any form without written permission from the ESC. Permission can be obtained upon submission of a written request to
22 wrz 2023 · ESC Policies and Procedures for formulating and issuing ESC Guidelines can be found on the ESC website (https://www.escardio.org/Guidelines).
30 sie 2021 · A 10-year CVD risk of 7.5 to <15% is considered ‘high risk’, and treatment of risk factors should be considered taking CVD risk modifiers, frailty, lifetime treatment benefit (in low and moderate risk regions, Box 1), comorbidities, polypharmacy, and patient preferences into account.
